{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fpce.simplecast.com%2Fepisodes%2Fsars-cov-2-variants-and-the-future-tZZNc81x","width":444,"version":"1.0","type":"rich","title":"SARS-CoV-2 Variants and the Future","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/947d3b7f-3890-4e80-8529-6486b02916d4/e50b7b9b-7abf-412a-8b5f-de54ebd7fdc0/covid-podcast-sars-cov-2-variants-and-the-future-episode6.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/c4cd17ac-5371-4a20-a8fb-168f5a53236a\" height=\"200\" width=\"100%\" title=\"SARS-CoV-2 Variants and the Future\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"In this last episode of the 6-part series, an expert describes what is known about the SARS-CoV-2 variants—including the UK, South African, and Brazilian variants that are becoming more prevalent in the United States. The discussion then focuses on how these variants impact the efficacy of vaccines and monoclonal antibodies. Claim your credit at pce.is/COV19."}